Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrazoxane in Congenital Heart Surgery
NCT02519335Phase 1Terminated
- Sponsor
- Medical City Children's Hospital
- Start
- Sep 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexrazoxane in congenital heart defects (CHD), sponsored by Medical City Children's Hospital. Primary endpoint: Resolution of organ failure at 60 days. Started Sep 2014; status: terminated.
02
Drugs
dexrazoxane
03
Conditions
congenital heart defects (CHD)
Beyond the preview
Go deeper on NCT02519335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519335.